Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025)
Siga Technologies (SIGA) posted Current Deferred Revenue of $10.2 million for Q4 2025, little changed on a QoQ basis from $10.2 million in Q3 2025, and down 0.88% year-over-year from $10.3 million in Q4 2024.
Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Siga Technologies' Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $10.2 million for Q4 2025.
- Quarterly Current Deferred Revenue fell 0.88% year-over-year to $10.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 million (down 0.88% YoY) and the FY2025 annual result came in at $10.2 million, down 0.88% from the prior year.
- Current Deferred Revenue was $10.2 million for Q4 2025 at Siga Technologies, roughly flat from $10.2 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $21.9 million in Q3 2023 and bottomed at $300000.0 in Q4 2022.
- A 5-year average of $10.1 million and a median of $10.2 million in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue plunged 90.62% — and 2023, when it jumped 6829.57%.
- Siga Technologies' Current Deferred Revenue stood at $3.2 million in 2021, then plunged by 90.62% to $300000.0 in 2022, then soared by 6829.57% to $20.8 million in 2023, then tumbled by 50.31% to $10.3 million in 2024, then fell by 0.88% to $10.2 million in 2025.
- Business Quant data shows SIGA's Current Deferred Revenue at $10.2 million in Q4 2025, $10.2 million in Q3 2025, and $10.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 10.24 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 10.33 Mn |
| Sep 30, 2024 | 13.73 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Dec 31, 2023 | 20.79 Mn |
| Sep 30, 2023 | 21.90 Mn |
| Jun 30, 2023 | 11.37 Mn |
| Mar 31, 2023 | 10.52 Mn |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 10.13 Mn |
| Jun 30, 2022 | 7.04 Mn |
| Mar 31, 2022 | 793,464.00 |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | 3.59 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 3.28 Mn |